UHA Medical Drug List

Size: px
Start display at page:

Download "UHA Medical Drug List"

Transcription

1 for pricing information The following is a list of drugs that are covered under the medical benefit. The cost share may be dependent on the diagnosis and/or the dose prescribed by your physician. Customer Service at (Oahu) or (neighbor islands) for more information. Drug Name Cost indicator Requirements 5% DEXTROSE/NORMAL SALINE (500 ML = 1 UNIT) PA 5% DEXTROSE/WATER (500 ML = 1 UNIT) Abraxane PA Actemra IV PA Actemra SC PA Actimmune PA Adcetris PA Adcirca PA Adempas PA Adrucil PA Alimta PA Alkeran PA Amifostine PA AMINOLEVULINIC ACID HCL FOR TOPICAL ADMINISTRATION, 20%, SIN Ampyra PA ANTI INHIBITOR, PER I.U. ANTITHROMBIN III (HUMAN), PER I.U. PA Aralast NP PA Aranesp PA Arcalyst PA Arranon PA Arzerra PA Aubagio PA Avastin PA Avonex PA Azacitidine PA AZATHIOPRINE, PARENTERAL, 100 MG PA BACILLUS CALMETTE GUERIN VACCINE (BCG) FOR TUBERCULOSIS, LIV $0 PA BCG (INTRAVESICAL) PER INSTILLATION PA Beleodaq PA Bendeka PA Berinert PA 1

2 for pricing information Betaseron PA Bicnu PA Bivigam PA Bleomycin Sulfate PA Blincyto PA Boniva PA Botox PA BOTULINUM ANTITOXIN, EQUINE, ANY ROUTE BOTULISM IMMUNE GLOBULIN, HUMAN, FOR INTRAVENOUS USE Busulfex PA Calcium Folinate PA Camptosar PA Capecitabine PA Carboplatin PA Carimune NF PA Cimzia PA Cinryze PA Cisplatin PA Cladribine PA Clolar PA CONTRACEPTIVE SUPPLY, HORMONE CONTAINING VAGINAL RING, EACH Copaxone PA Copegus PA Cosentyx PA Cosmegen PA Cyclophosphamide PA CYCLOPHOSPHAMIDE, 100 MG CYCLOSPORIN, PARENTERAL, 250 MG Cyramza PA Cytarabine PA CYTOMEGALOVIRUS IMMUNE GLOBULIN (CMV IGIV), HUMAN, FOR INTRA Dacarbazine PA DACARBAZINE, 100 MG DACLIZUMAB, PARENTERAL, 25 MG Dacogen PA Daklinza PA Darzalex PA 2

3 for pricing information Daunorubicin HCl PA Daunoxome PA Decitabine PA Delatestryl PA Depo Testosterone PA Depocyst PA Dexrazoxane PA DIPHTHERIA AND TETANUS TOXOIDS ADSORBED (DT) WHEN ADMINISTER $0 DIPHTHERIA ANTITOXIN, EQUINE, ANY ROUTE DIPHTHERIA, TETANUS TOXOIDS, ACELLULAR PERTUSSIS VACCINE AND $0 DIPHTHERIA, TETANUS TOXOIDS, ACELLULAR PERTUSSIS VACCINE, HA $0 DIPHTHERIA, TETANUS TOXOIDS, ACELLULAR PERTUSSIS VACCINE, HE $0 DIPHTHERIA, TETANUS TOXOIDS, AND ACELLULAR PERTUSSIS VACCINE $0 Docefrez PA Docetaxel PA Doxil PA Doxorubicin HCl PA DRUG ADMINISTERED THROUGH A METERED DOSE INHALER Dysport PA EDETATE DISODIUM, PER 150 MG Egrifta PA Eligard PA Elitek PA Ellence PA Empliciti PA Enbrel PA Entyvio PA Epirubicin HCl PA Epogen PA Epoprostenol Sodium PA Erbitux PA Erbitux PA Erwinaze PA Esbriet PA 3

4 for pricing information ETONOGESTREL (CONTRACEPTIVE) IMPLANT SYSTEM, INCLUDING IMPLA Etopophos PA Etoposide PA Euflexxa PA Extavia PA Eylea PA FACTOR IX (ANTIHEMOPHILIC FACTOR, PURIFIED, NON RECOMBINANT) $$$$$ FACTOR IX, COMPLEX, PER I.U. FACTOR VIIA (ANTIHEMOPHILIC FACTOR, RECOMBINANT), PER 1 MICR 4 FACTOR VIII (ANTIHEMOPHILIC FACTOR (PORCINE)), PER I.U. PA FACTOR VIII (ANTIHEMOPHILIC FACTOR, HUMAN) PER I.U. PA FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) PER I.U., N $$$$$ Faslodex PA Firazyr PA Firmagon PA Flebogamma DIF PA Flolan PA Floxuridine PA Fludarabine Phosphate PA FLUOCINOLONE ACETONIDE, INTRAVITREAL IMPLANT Fluorouracil PA Folotyn PA Forteo PA Fusilev PA Gammagard Liquid PA Gammagard S/D PA Gammaked PA Gammaplex PA Gamunex C PA GANCICLOVIR, 4.5 MG, LONG ACTING IMPLANT PA Gazyva PA Gel One PA Gemcitabine HCl PA Gemzar PA Genotropin PA GenVisc PA

5 for pricing information Gilenya PA Glassia PA Glatopa PA GOSERELIN ACETATE IMPLANT, PER 3.6 MG PA Granix PA Grastek PA HAEMOPHILUS INFLUENZAE TYPE B VACCINE (HIB), PRP OMP CONJUGA $0 PA HAEMOPHILUS INFLUENZAE TYPE B VACCINE (HIB), PRP T CONJUGATE $0 PA Halaven PA Harvoni PA HEMOPHILIA CLOTTING FACTOR, NOT OTHERWISE CLASSIFIED PA HEPATITIS A AND HEPATITIS B VACCINE (HEPA HEPB), ADULT DOSAG $0 PA HEPATITIS A VACCINE (HEPA), ADULT DOSAGE, FOR INTRAMUSCULAR PA HEPATITIS A VACCINE (HEPA), PEDIATRIC/ADOLESCENT DOSAGE 2 DO $0 PA HEPATITIS A VACCINE (HEPA), PEDIATRIC/ADOLESCENT DOSAGE 3 DO $0 PA HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE (HIB H $0 PA HEPATITIS B IMMUNE GLOBULIN (HBIG), HUMAN, FOR INTRAMUSCULAR PA HEPATITIS B VACCINE (HEPB), ADOLESCENT, 2 DOSE SCHEDULE, FOR $0 PA HEPATITIS B VACCINE (HEPB), ADULT DOSAGE, 3 DOSE SCHEDULE, F $0 PA HEPATITIS B VACCINE (HEPB), DIALYSIS OR IMMUNOSUPPRESSED PAT $0 PA HEPATITIS B VACCINE (HEPB), DIALYSIS OR IMMUNOSUPPRESSED PAT $0 PA HEPATITIS B VACCINE (HEPB), PEDIATRIC/ADOLESCENT DOSAGE, 3 D $0 PA Herceptin PA Hetlioz PA Hizentra PA HP Acthar PA Humatrope PA Humira PA Hyalgan PA HYALURONAN OR DERIVATIVE, EUFLEXXA, FOR INTRA ARTICULAR INJE HYALURONAN OR DERIVATIVE, HYALGAN OR SUPARTZ, FOR INTRA ARTI 5

6 for pricing information HYALURONAN OR DERIVATIVE, MONOVISC, FOR INTRA ARTICULAR INJE HYALURONAN OR DERIVATIVE, ORTHOVISC, FOR INTRA ARTICULAR INJ PA HYALURONAN OR DERIVATIVE, SYNVISC OR SYNVISC ONE, FOR INTRA PA Hycamtin PA HyQvia PA Idamycin PFS PA Idarubicin HCl PA Ifex PA Ifosfamide PA Ilaris PA Imlygic PA IMMUNE GLOBULIN (IG), HUMAN, FOR INTRAMUSCULAR USE PA IMMUNE GLOBULIN (IGIV), HUMAN, FOR INTRAVENOUS USE IMMUNOSUPPRESSIVE DRUG, NOT OTHERWISE CLASSIFIED 6 Increlex PA INFLUENZA VACCINE, INACTIVATED (IIV), SUBUNIT, ADJUVANTED, F $0 INFLUENZA VIRUS VACCINE (IIV), PANDEMIC FORMULATION, SPLIT V $0 INFLUENZA VIRUS VACCINE (IIV), PANDEMIC FORMULATION, SPLIT V $0 INFLUENZA VIRUS VACCINE (IIV), PANDEMIC FORMULATION, SPLIT V $0 INFLUENZA VIRUS VACCINE (IIV), SPLIT VIRUS, PRESERVATIVE FRE $0 PA INFLUENZA VIRUS VACCINE, LIVE (LAIV), PANDEMIC FORMULATION, $0 PA INFLUENZA VIRUS VACCINE, QUADRIVALENT (IIV4), SPLIT VIRUS, 0 $0 PA INFLUENZA VIRUS VACCINE, QUADRIVALENT (IIV4), SPLIT VIRUS, 0 $0 PA INFLUENZA VIRUS VACCINE, QUADRIVALENT (IIV4), SPLIT VIRUS, P $0 INFLUENZA VIRUS VACCINE, QUADRIVALENT (IIV4), SPLIT VIRUS, P $0 INFLUENZA VIRUS VACCINE, QUADRIVALENT (IIV4), SPLIT VIRUS, P $0 INFLUENZA VIRUS VACCINE, QUADRIVALENT, LIVE (LAIV4), FOR INT $0 INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO I $0 INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO I $0 INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO I $0 INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO I $0 INFLUENZA VIRUS VACCINE, TRIVALENT (CCIIV3), DERIVED FROM CE INFLUENZA VIRUS VACCINE, TRIVALENT (IIV3), SPLIT VIRUS, 0.25 $0 INFLUENZA VIRUS VACCINE, TRIVALENT (IIV3), SPLIT VIRUS, 0.5 $0 INFLUENZA VIRUS VACCINE, TRIVALENT (IIV3), SPLIT VIRUS, PRES $0 INFLUENZA VIRUS VACCINE, TRIVALENT (IIV3), SPLIT VIRUS, PRES $0

7 for pricing information INFLUENZA VIRUS VACCINE, TRIVALENT (IIV3), SPLIT VIRUS, PRES $0 INFLUENZA VIRUS VACCINE, TRIVALENT (RIV3), DERIVED FROM RECO $0 INFLUENZA VIRUS VACCINE, TRIVALENT, LIVE (LAIV3), FOR INTRAN $0 INFUSION, D5W, 1000 CC INFUSION, DEXTRAN 40, 500 ML INFUSION, DEXTRAN 75, 500 ML PA INFUSION, NORMAL SALINE SOLUTION, 1000 CC INFUSION, NORMAL SALINE SOLUTION, 250 CC INFUSION, NORMAL SALINE SOLUTION, STERILE (500 ML = 1 UNIT) INJECTION ABCIXIMAB, 10 MG INJECTION FLUCONAZOLE, 200 MG INJECTION PROCEDURE DURING CARDIAC CATHETERIZATION INCLUDING $0 PA INJECTION PROCEDURE DURING CARDIAC CATHETERIZATION INCLUDING PA INJECTION PROCEDURE DURING CARDIAC CATHETERIZATION INCLUDING INJECTION PROCEDURE DURING CARDIAC CATHETERIZATION INCLUDING PA INJECTION PROCEDURE DURING CARDIAC CATHETERIZATION INCLUDING INJECTION, ABATACEPT, 10 MG (CODE MAY BE USED FOR MEDICARE W PA INJECTION, ABOBOTULINUMTOXINA, 5 UNITS PA INJECTION, ACETAMINOPHEN, 10 MG PA INJECTION, ACETAZOLAMIDE SODIUM, UP TO 500 MG PA INJECTION, ACYCLOVIR, 5 MG INJECTION, ADALIMUMAB, 20 MG INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADE PA INJECTION, ADO TRASTUZUMAB EMTANSINE, 1 MG $$$$$ INJECTION, ADRENALIN, EPINEPHRINE, 0.1 MG PA INJECTION, AFLIBERCEPT, 1 MG PA INJECTION, AGALSIDASE BETA, 1 MG PA INJECTION, ALATROFLOXACIN MESYLATE, 100 MG INJECTION, ALEFACEPT, 0.5 MG INJECTION, ALEMTUZUMAB, 1 MG INJECTION, ALGLUCERASE, PER 10 UNITS INJECTION, ALGLUCOSIDASE ALFA, (LUMIZYME), 10 MG INJECTION, ALPHA 1 PROTEINASE INHIBITOR (HUMAN), (GLASSIA), PA 7

8 for pricing information INJECTION, ALPHA 1 PROTEINASE INHIBITOR (HUMAN), NOT OTHERWI PA INJECTION, ALTEPLASE RECOMBINANT, 1 MG PA INJECTION, AMIFOSTINE, 500 MG PA INJECTION, AMINOPHYLLIN, UP TO 250 MG PA INJECTION, AMITRIPTYLINE HCL, UP TO 20 MG PA INJECTION, AMOBARBITAL, UP TO 125 MG INJECTION, AMPHOTERICIN B, 50 MG INJECTION, AMPICILLIN SODIUM, 500 MG INJECTION, AMPICILLIN SODIUM/SULBACTAM SODIUM, PER 1.5 GM 8 INJECTION, ANISTREPLASE, PER 30 UNITS PA INJECTION, ARBUTAMINE HCL, 1 MG INJECTION, ARIPIPRAZOLE, EXTENDED RELEASE, 1 MG INJECTION, ATROPINE SULFATE, 0.01 MG INJECTION, AUROTHIOGLUCOSE, UP TO 50 MG INJECTION, AZACITIDINE, 1 MG INJECTION, AZITHROMYCIN, 500 MG PA INJECTION, BACLOFEN, 10 MG PA INJECTION, BACLOFEN, 50 MCG FOR INTRATHECAL TRIAL INJECTION, BELATACEPT, 1 MG INJECTION, BELIMUMAB, 10 MG INJECTION, BENDAMUSTINE HCL (TREANDA), 1 MG INJECTION, BENZTROPINE MESYLATE, PER 1 MG INJECTION, BETAMETHASONE ACETATE 3 MG AND BETAMETHASONE SODI INJECTION, BETHANECHOL CHLORIDE, MYOTONACHOL OR URECHOLINE, INJECTION, BEVACIZUMAB, 10 MG INJECTION, BIPERIDEN LACTATE, PER 5 MG PA INJECTION, BLEOMYCIN SULFATE, 15 UNITS INJECTION, BORTEZOMIB, 0.1 MG INJECTION, BROMPHENIRAMINE MALEATE, PER 10 MG INJECTION, BUPIVICAINE HYDROCHLORIDE, 30 ML PA INJECTION, BUTORPHANOL TARTRATE, 1 MG PA INJECTION, C 1 ESTERASE INHIBITOR (HUMAN), BERINERT, 10 UNIT PA INJECTION, C 1 ESTERASE INHIBITOR (HUMAN), CINRYZE, 10 UNITS PA INJECTION, C1 ESTERASE INHIBITOR (RECOMBINANT), RUCONEST, 10 PA INJECTION, CALCITONIN SALMON, UP TO 400 UNITS PA INJECTION, CALCIUM GLUCONATE, PER 10 ML PA

9 for pricing information INJECTION, CALCIUM GLYCEROPHOSPHATE AND CALCIUM LACTATE, PER INJECTION, CANAKINUMAB, 1 MG INJECTION, CARBOPLATIN, 50 MG 9 INJECTION, CARFILZOMIB, 1 MG PA INJECTION, CEFAZOLIN SODIUM, 500 MG PA INJECTION, CEFEPIME HYDROCHLORIDE, 500 MG INJECTION, CEFOTAXIME SODIUM, PER GM $0 PA INJECTION, CEFOXITIN SODIUM, 1 GM PA INJECTION, CEFTAROLINE FOSAMIL, 10 MG PA INJECTION, CEFTAZIDIME, PER 500 MG INJECTION, CEFTIZOXIME SODIUM, PER 500 MG INJECTION, CEFTRIAXONE SODIUM, PER 250 MG INJECTION, CEPHALOTHIN SODIUM, UP TO 1 GRAM INJECTION, CEPHAPIRIN SODIUM, UP TO 1 GM INJECTION, CERTOLIZUMAB PEGOL, 1 MG (CODE MAY BE USED FOR ME INJECTION, CETUXIMAB, 10 MG PA INJECTION, CHLORAMPHENICOL SODIUM SUCCINATE, UP TO 1 GM PA INJECTION, CHLORDIAZEPOXIDE HCL, UP TO 100 MG INJECTION, CHLOROPROCAINE HYDROCHLORIDE, PER 30 ML INJECTION, CHLOROQUINE HYDROCHLORIDE, UP TO 250 MG INJECTION, CHLOROTHIAZIDE SODIUM, PER 500 MG INJECTION, CHLORPROMAZINE HCL, UP TO 50 MG INJECTION, CHORIONIC GONADOTROPIN, PER 1,000 USP UNITS INJECTION, CIDOFOVIR, 375 MG INJECTION, CILASTATIN SODIUM; IMIPENEM, PER 250 MG $0 INJECTION, CIMETIDINE HYDROCHLORIDE, 300 MG INJECTION, CIPROFLOXACIN FOR INTRAVENOUS INFUSION, 200 MG PA INJECTION, CISPLATIN, POWDER OR SOLUTION, 10 MG PA INJECTION, CLADRIBINE, PER 1 MG $0 PA INJECTION, CLINDAMYCIN PHOSPHATE, 300 MG INJECTION, CLONIDINE HYDROCHLORIDE, 1 MG INJECTION, CODEINE PHOSPHATE, PER 30 MG INJECTION, COLISTIMETHATE SODIUM, UP TO 150 MG INJECTION, COLLAGENASE, CLOSTRIDIUM HISTOLYTICUM, 0.01 MG $$$$$ INJECTION, CORTICOTROPIN, UP TO 40 UNITS $$$$$ INJECTION, COSYNTROPIN (CORTROSYN), 0.25 MG INJECTION, CYTARABINE LIPOSOME, 10 MG

10 for pricing information INJECTION, CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMA PA INJECTION, DALBAVANCIN, 5 MG INJECTION, DALTEPARIN SODIUM, PER 2500 IU INJECTION, DAPTOMYCIN, 1 MG INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (FOR ESRD ON DIALYS 10 INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (NON ESRD USE) PA INJECTION, DECITABINE, 1 MG PA INJECTION, DEFEROXAMINE MESYLATE, 500 MG PA INJECTION, DEGARELIX, 1 MG $0 INJECTION, DENOSUMAB, 1 MG INJECTION, DEPO ESTRADIOL CYPIONATE, UP TO 5 MG INJECTION, DEXAMETHASONE ACETATE, 1 MG INJECTION, DEXAMETHASONE SODIUM PHOSPHATE, 1 MG INJECTION, DEXAMETHASONE, INTRAVITREAL IMPLANT, 0.1 MG INJECTION, DEXRAZOXANE HYDROCHLORIDE, PER 250 MG INJECTION, DIAZEPAM, UP TO 5 MG PA INJECTION, DIAZOXIDE, UP TO 300 MG PA INJECTION, DICYCLOMINE HCL, UP TO 20 MG INJECTION, DIGOXIN, UP TO 0.5 MG PA INJECTION, DIHYDROERGOTAMINE MESYLATE, PER 1 MG PA INJECTION, DIMENHYDRINATE, UP TO 50 MG INJECTION, DIMERCAPROL, PER 100 MG PA INJECTION, DIPHENHYDRAMINE HCL, UP TO 50 MG PA INJECTION, DIPYRIDAMOLE, PER 10 MG INJECTION, DMSO, DIMETHYL SULFOXIDE, 50%, 50 ML INJECTION, DOBUTAMINE HYDROCHLORIDE, PER 250 MG INJECTION, DOCETAXEL, 1 MG INJECTION, DOLASETRON MESYLATE, 10 MG PA INJECTION, DOXORUBICIN HYDROCHLORIDE, 10 MG PA INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWI INJECTION, DROPERIDOL AND FENTANYL CITRATE, UP TO 2 ML AMPUL PA INJECTION, DROPERIDOL, UP TO 5 MG PA INJECTION, DYPHYLLINE, UP TO 500 MG INJECTION, EDETATE CALCIUM DISODIUM, UP TO 1000 MG PA INJECTION, ELOSULFASE ALFA, 1 MG

11 for pricing information INJECTION, ENFUVIRTIDE, 1 MG PA INJECTION, ENOXAPARIN SODIUM, 10 MG PA INJECTION, EPOETIN ALFA, (FOR NON ESRD USE), 1000 UNITS PA INJECTION, EPOETIN BETA, 1 MICROGRAM, (FOR ESRD ON DIALYSIS) 11 INJECTION, EPOETIN BETA, 1 MICROGRAM, (FOR NON ESRD USE) PA INJECTION, EPOPROSTENOL, 0.5 MG PA INJECTION, EPTIFIBATIDE, 5 MG PA INJECTION, ERGONOVINE MALEATE, UP TO 0.2 MG INJECTION, ERTAPENEM SODIUM, 500 MG PA INJECTION, ERYTHROMYCIN LACTOBIONATE, PER 500 MG $0 PA INJECTION, ESTRADIOL VALERATE, UP TO 10 MG PA INJECTION, ESTROGEN CONJUGATED, PER 25 MG INJECTION, ESTRONE, PER 1 MG INJECTION, ETANERCEPT, 25 MG (CODE MAY BE USED FOR MEDICARE PA INJECTION, ETIDRONATE DISODIUM, PER 300 MG PA INJECTION, ETOPOSIDE, 10 MG PA INJECTION, FACTOR IX (ANTIHEMOPHILIC FACTOR, RECOMBINANT) PE PA INJECTION, FACTOR IX, (ANTIHEMOPHILIC FACTOR, RECOMBINANT), PA INJECTION, FAMOTIDINE, 20 MG INJECTION, FENTANYL CITRATE, 0.1 MG PA INJECTION, FERRIC CARBOXYMALTOSE, 1 MG PA INJECTION, FERRIC PYROPHOSPHATE CITRATE SOLUTION, 0.1 MG OF INJECTION, FERUMOXYTOL, FOR TREATMENT OF IRON DEFICIENCY ANE INJECTION, FILGRASTIM (G CSF), BIOSIMILAR, 1 MICROGRAM INJECTION, FILGRASTIM (G CSF), EXCLUDES BIOSIMILARS, 1 MICRO INJECTION, FLUOCINOLONE ACETONIDE, INTRAVITREAL IMPLANT, 0.0 INJECTION, FLUOROURACIL, 500 MG INJECTION, FLUPHENAZINE DECANOATE, UP TO 25 MG INJECTION, FONDAPARINUX SODIUM, 0.5 MG INJECTION, FOSAPREPITANT, 1 MG INJECTION, FOSCARNET SODIUM, PER 1000 MG INJECTION, FULVESTRANT, 25 MG INJECTION, FUROSEMIDE, UP TO 20 MG INJECTION, GADOLINIUM BASED MAGNETIC RESONANCE CONTRAST AGEN INJECTION, GALSULFASE, 1 MG

12 for pricing information INJECTION, GAMMA GLOBULIN, INTRAMUSCULAR, 1 CC PA INJECTION, GAMMA GLOBULIN, INTRAMUSCULAR, OVER 10 CC PA INJECTION, GANCICLOVIR SODIUM, 500 MG INJECTION, GARAMYCIN, GENTAMICIN, UP TO 80 MG 12 INJECTION, GEMCITABINE HYDROCHLORIDE, 200 MG PA INJECTION, GLATIRAMER ACETATE, 20 MG INJECTION, GLUCAGON HYDROCHLORIDE, PER 1 MG INJECTION, GOLD SODIUM THIOMALATE, UP TO 50 MG PA INJECTION, GOLIMUMAB, 1 MG, FOR INTRAVENOUS USE PA INJECTION, GONADORELIN HYDROCHLORIDE, PER 100 MCG PA INJECTION, GRANISETRON HYDROCHLORIDE, 100 MCG INJECTION, HALOPERIDOL DECANOATE, PER 50 MG INJECTION, HALOPERIDOL, UP TO 5 MG INJECTION, HEPARIN SODIUM, (HEPARIN LOCK FLUSH), PER 10 UNIT INJECTION, HEPARIN SODIUM, PER 1000 UNITS INJECTION, HYALURONIDASE, UP TO 150 UNITS INJECTION, HYDRALAZINE HCL, UP TO 20 MG INJECTION, HYDROCORTISONE ACETATE, UP TO 25 MG PA INJECTION, HYDROCORTISONE SODIUM PHOSPHATE, UP TO 50 MG INJECTION, HYDROCORTISONE SODIUM SUCCINATE, UP TO 100 MG PA INJECTION, HYDROMORPHONE, UP TO 4 MG PA INJECTION, HYDROXYPROGESTERONE CAPROATE, 1 MG INJECTION, HYDROXYZINE HCL, UP TO 25 MG INJECTION, HYOSCYAMINE SULFATE, UP TO 0.25 MG INJECTION, IBANDRONATE SODIUM, 1 MG INJECTION, IBUTILIDE FUMARATE, 1 MG INJECTION, IDURSULFASE, 1 MG INJECTION, IMIGLUCERASE, 10 UNITS PA INJECTION, IMMUNE GLOBULIN (HIZENTRA), 100 MG PA INJECTION, IMMUNE GLOBULIN (PRIVIGEN), INTRAVENOUS, NON LYOP PA INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG PA INJECTION, IMMUNE GLOBULIN, (FLEBOGAMMA/FLEBOGAMMA DIF), INT INJECTION, IMMUNE GLOBULIN, (GAMMAGARD LIQUID), NON LYOPHILI INJECTION, IMMUNE GLOBULIN, (GAMUNEX C/GAMMAKED), NON LYOPHI INJECTION, IMMUNE GLOBULIN, (OCTAGAM), INTRAVENOUS, NON LYOP

13 for pricing information INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, LYOPHILIZED (E.G., INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT INJECTION, INFLIXIMAB, EXCLUDES BIOSIMILAR, 10 MG INJECTION, INSULIN, PER 5 UNITS INJECTION, INTERFERON ALFACON 1, RECOMBINANT, 1 MICROGRAM INJECTION, INTERFERON BETA 1A, 1 MCG FOR INTRAMUSCULAR USE $$$$$ INJECTION, INTERFERON BETA 1A, 1 MCG FOR SUBCUTANEOUS USE $0 PA INJECTION, INTERFERON BETA 1A, 30 MCG $$$$$ INJECTION, INTERFERON BETA 1B, 0.25 MG (CODE MAY BE USED FOR INJECTION, INTERFERON, ALFA 2A, RECOMBINANT, 3 MILLION UNITS INJECTION, INTERFERON, ALFA 2B, RECOMBINANT, 1 MILLION UNITS INJECTION, INTERFERON, ALFA N3, (HUMAN LEUKOCYTE DERIVED), 2 PA INJECTION, IPILIMUMAB, 1 MG $0 INJECTION, IRINOTECAN, 20 MG INJECTION, IRON DEXTRAN, 50 MG INJECTION, IRON SUCROSE, 1 MG INJECTION, ITRACONAZOLE, 50 MG PA INJECTION, IV, UROKINASE, 250,000 I.U. VIAL INJECTION, IXABEPILONE, 1 MG $0 PA INJECTION, KANAMYCIN SULFATE, UP TO 500 MG PA INJECTION, KANAMYCIN SULFATE, UP TO 75 MG INJECTION, KETOROLAC TROMETHAMINE, PER 15 MG INJECTION, LEUCOVORIN CALCIUM, PER 50 MG PA INJECTION, LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), PER 3. PA INJECTION, LEVOCARNITINE, PER 1 GM INJECTION, LEVOFLOXACIN, 250 MG INJECTION, LEVORPHANOL TARTRATE, UP TO 2 MG INJECTION, LIDOCAINE HCL FOR INTRAVENOUS INFUSION, 10 MG INJECTION, LINCOMYCIN HCL, UP TO 300 MG INJECTION, LORAZEPAM, 2 MG PA INJECTION, MAGNESIUM SULFATE, PER 500 MG INJECTION, MANNITOL, 25% IN 50 ML INJECTION, MECASERMIN, 1 MG INJECTION, MEDROXYPROGESTERONE ACETATE, 1 MG PA INJECTION, MEPERIDINE AND PROMETHAZINE HCL, UP TO 50 MG INJECTION, MEPERIDINE HYDROCHLORIDE, PER 100 MG PA INJECTION, MEPIVACAINE HYDROCHLORIDE, PER 10 ML PA 13

14 for pricing information INJECTION, MEROPENEM, 100 MG PA INJECTION, METARAMINOL BITARTRATE, PER 10 MG PA INJECTION, METHADONE HCL, UP TO 10 MG INJECTION, METHOCARBAMOL, UP TO 10 ML INJECTION, METHYLDOPATE HCL, UP TO 250 MG INJECTION, METHYLERGONOVINE MALEATE, UP TO 0.2 MG INJECTION, METHYLNALTREXONE, 0.1 MG INJECTION, METHYLPREDNISOLONE ACETATE, 20 MG INJECTION, METHYLPREDNISOLONE ACETATE, 40 MG INJECTION, METHYLPREDNISOLONE ACETATE, 80 MG INJECTION, METHYLPREDNISOLONE SODIUM SUCCINATE, UP TO 125 MG INJECTION, METHYLPREDNISOLONE SODIUM SUCCINATE, UP TO 40 MG 14 INJECTION, METOCLOPRAMIDE HCL, UP TO 10 MG PA INJECTION, MIDAZOLAM HYDROCHLORIDE, PER 1 MG INJECTION, MILRINONE LACTATE, 5 MG INJECTION, MORPHINE SULFATE, UP TO 10 MG INJECTION, NALBUPHINE HYDROCHLORIDE, PER 10 MG $0 INJECTION, NALOXONE HYDROCHLORIDE, PER 1 MG INJECTION, NALTREXONE, DEPOT FORM, 1 MG INJECTION, NANDROLONE DECANOATE, UP TO 50 MG INJECTION, NATALIZUMAB, 1 MG INJECTION, NEOSTIGMINE METHYLSULFATE, UP TO 0.5 MG INJECTION, NIVOLUMAB, 1 MG $$$$$ INJECTION, OCRIPLASMIN, MG PA INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTIO PA INJECTION, OMACETAXINE MEPESUCCINATE, 0.01 MG INJECTION, OMALIZUMAB, 5 MG PA INJECTION, ONABOTULINUMTOXINA, 1 UNIT INJECTION, ONDANSETRON HYDROCHLORIDE, PER 1 MG INJECTION, OPRELVEKIN, 5 MG INJECTION, ORPHENADRINE CITRATE, UP TO 60 MG INJECTION, OXACILLIN SODIUM, UP TO 250 MG INJECTION, OXALIPLATIN, 0.5 MG INJECTION, OXYMORPHONE HCL, UP TO 1 MG PA INJECTION, OXYTETRACYCLINE HCL, UP TO 50 MG PA INJECTION, OXYTOCIN, UP TO 10 UNITS

15 for pricing information INJECTION, PACLITAXEL PROTEIN BOUND PARTICLES, 1 MG INJECTION, PACLITAXEL, 1 MG INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE, 1 MG INJECTION, PALONOSETRON HCL, 25 MCG 15 INJECTION, PAMIDRONATE DISODIUM, PER 30 MG $0 PA INJECTION, PANITUMUMAB, 10 MG $$$$$ INJECTION, PANTOPRAZOLE SODIUM, 40 MG INJECTION, PAPAVERINE HCL, UP TO 60 MG $0 INJECTION, PEGAPTANIB SODIUM, 0.3 MG INJECTION, PEGFILGRASTIM, 6 MG PA INJECTION, PEGYLATED INTERFERON ALFA 2A, 180 MCG PER ML $0 PA INJECTION, PEMETREXED, 10 MG PA INJECTION, PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE PA INJECTION, PENICILLIN G BENZATHINE, 100,000 UNITS PA INJECTION, PENICILLIN G POTASSIUM, UP TO 600,000 UNITS PA INJECTION, PENICILLIN G PROCAINE, AQUEOUS, UP TO 600,000 UNI PA INJECTION, PENTAZOCINE, 30 MG PA INJECTION, PENTOBARBITAL SODIUM, PER 50 MG PA INJECTION, PERFLUTREN LIPID MICROSPHERES, PER ML PA INJECTION, PERPHENAZINE, UP TO 5 MG INJECTION, PERTUZUMAB, 1 MG $$$$$ INJECTION, PHENOBARBITAL SODIUM, UP TO 120 MG $0 INJECTION, PHENTOLAMINE MESYLATE, UP TO 5 MG INJECTION, PHENYLEPHRINE HCL, UP TO 1 ML INJECTION, PHENYTOIN SODIUM, PER 50 MG INJECTION, PHYTONADIONE (VITAMIN K), PER 1 MG $0 INJECTION, PIPERACILLIN SODIUM/TAZOBACTAM SODIUM, 1 GRAM/0.1 INJECTION, PLERIXAFOR, 1 MG INJECTION, POTASSIUM CHLORIDE, PER 2 MEQ PA INJECTION, PRALATREXATE, 1 MG $$$$$ PA INJECTION, PRALIDOXIME CHLORIDE, UP TO 1 GM INJECTION, PREDNISOLONE ACETATE, UP TO 1 ML INJECTION, PROCAINAMIDE HCL, UP TO 1 GM INJECTION, PROCHLORPERAZINE, UP TO 10 MG INJECTION, PROGESTERONE, PER 50 MG INJECTION, PROMAZINE HCL, UP TO 25 MG PA INJECTION, PROMETHAZINE HCL, UP TO 50 MG PA

16 for pricing information INJECTION, PROPOFOL, 10 MG PA INJECTION, PROPRANOLOL HCL, UP TO 1 MG INJECTION, PROTAMINE SULFATE, PER 10 MG 16 INJECTION, PROTIRELIN, PER 250 MCG PA INJECTION, PYRIDOXINE HCL, 100 MG INJECTION, RANIBIZUMAB, 0.1 MG INJECTION, RANITIDINE HYDROCHLORIDE, 25 MG INJECTION, REGADENOSON, 0.1 MG INJECTION, RHO D IMMUNE GLOBULIN, HUMAN, FULL DOSE, 300 MICR INJECTION, RHO D IMMUNE GLOBULIN, HUMAN, MINIDOSE, 50 MICROG INJECTION, RHO D IMMUNE GLOBULIN, INTRAVENOUS, HUMAN, SOLVEN PA INJECTION, RHO(D) IMMUNE GLOBULIN (HUMAN), (RHOPHYLAC), INTR PA INJECTION, RILONACEPT, 1 MG INJECTION, RIMABOTULINUMTOXINB, 100 UNITS INJECTION, RITUXIMAB, 100 MG INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG PA INJECTION, SARGRAMOSTIM (GM CSF), 50 MCG INJECTION, SERMORELIN ACETATE, 1 MICROGRAM INJECTION, SINCALIDE, 5 MICROGRAMS INJECTION, SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECT INJECTION, SOMATROPIN, 1 MG PA INJECTION, SPECTINOMYCIN DIHYDROCHLORIDE, UP TO 2 GM INJECTION, STERILE CEFUROXIME SODIUM, PER 750 MG $0 INJECTION, STREPTOKINASE, PER 250,000 IU INJECTION, STREPTOMYCIN, UP TO 1 GM INJECTION, SUCCINYLCHOLINE CHLORIDE, UP TO 20 MG INJECTION, SUMATRIPTAN SUCCINATE, 6 MG (CODE MAY BE USED FOR INJECTION, TALIGLUCERACE ALFA, 10 UNITS INJECTION, TBO FILGRASTIM, 1 MICROGRAM INJECTION, TEMOZOLOMIDE, 1 MG INJECTION, TEMSIROLIMUS, 1 MG INJECTION, TERBUTALINE SULFATE, UP TO 1 MG PA INJECTION, TERIPARATIDE, 10 MCG PA INJECTION, TESTOSTERONE CYPIONATE, 1 MG PA

17 for pricing information INJECTION, TESTOSTERONE ENANTHATE, 1 MG PA INJECTION, TESTOSTERONE UNDECANOATE, 1 MG PA INJECTION, TETANUS IMMUNE GLOBULIN, HUMAN, UP TO 250 UNITS PA INJECTION, TETRACYCLINE, UP TO 250 MG PA INJECTION, THEOPHYLLINE, PER 40 MG INJECTION, THIAMINE HCL, 100 MG INJECTION, THIETHYLPERAZINE MALEATE, UP TO 10 MG PA INJECTION, THYROTROPIN ALPHA, 0.9 MG, PROVIDED IN 1.1 MG VIA PA INJECTION, TOBRAMYCIN SULFATE, UP TO 80 MG PA INJECTION, TOCILIZUMAB, 1 MG PA INJECTION, TOLAZOLINE HCL, UP TO 25 MG PA INJECTION, TOPOTECAN, 0.1 MG $0 PA INJECTION, TORSEMIDE, 10 MG/ML PA INJECTION, TRASTUZUMAB, 10 MG INJECTION, TREPROSTINIL, 1 MG $$$$$ INJECTION, TRIAMCINOLONE ACETONIDE, NOT OTHERWISE SPECIFIED, INJECTION, TRIAMCINOLONE ACETONIDE, PRESERVATIVE FREE, 1 MG INJECTION, TRIAMCINOLONE DIACETATE, PER 5 MG INJECTION, TRIAMCINOLONE HEXACETONIDE, PER 5 MG INJECTION, TRIFLUPROMAZINE HCL, UP TO 20 MG INJECTION, TRIMETHOBENZAMIDE HCL, UP TO 200 MG $0 INJECTION, TRIMETREXATE GLUCURONATE, PER 25 MG INJECTION, TRIPTORELIN PAMOATE, 3.75 MG INJECTION, UREA, UP TO 40 GM INJECTION, UROFOLLITROPIN, 75 IU PA INJECTION, UROKINASE, 5000 IU VIAL INJECTION, VANCOMYCIN HCL, 500 MG INJECTION, VELAGLUCERASE ALFA, 100 UNITS INJECTION, VERTEPORFIN, 0.1 MG PA INJECTION, VINBLASTINE SULFATE, 1 MG INJECTION, VINCRISTINE SULFATE LIPOSOME, 1 MG INJECTION, VINORELBINE TARTRATE, 10 MG $0 INJECTION, VITAMIN B 12 CYANOCOBALAMIN, UP TO 1000 MCG INJECTION, ZIV AFLIBERCEPT, 1 MG $$$$$ INJECTION, ZOLEDRONIC ACID, 1 MG INTRAUTERINE COPPER CONTRACEPTIVE 17

18 for pricing information INTRAVENOUS INFUSION, FOR THERAPY, PROPHYLAXIS, OR DIAGNOSIS INTRAVENOUS INFUSION, FOR THERAPY, PROPHYLAXIS, OR DIAGNOSIS PA INTRAVENOUS INFUSION, FOR THERAPY, PROPHYLAXIS, OR DIAGNOSIS INTRAVENOUS INFUSION, FOR THERAPY, PROPHYLAXIS, OR DIAGNOSIS INTRAVENOUS INFUSION, HYDRATION; EACH ADDITIONAL HOUR (LIST INTRAVENOUS INFUSION, HYDRATION; INITIAL, 31 MINUTES TO 1 HO Intron A PA Irinotecan HCl PA Istodax PA Ixempra PA JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED, FOR INTRAM $0 PA Jevtana PA Kadcyla PA Kalbitor PA Kalydeco PA Kepivance PA Keytruda PA Kineret PA Korlym PA Krystexxa PA Kuvan PA Kyprolis PA Lemtrada PA Letairis PA Leucovorin Calcium PA Leuprolide Acetate PA LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG LEUPROLIDE ACETATE IMPLANT, 65 MG LEUPROLIDE ACETATE, PER 1 MG Levoleucovorin Calcium PA LEVONORGESTREL (CONTRACEPTIVE) IMPLANT SYSTEM, INCLUDING IMP LEVONORGESTREL RELEASING INTRAUTERINE CONTRACEPTIVE SYSTEM ( 18

19 for pricing information LEVONORGESTREL RELEASING INTRAUTERINE CONTRACEPTIVE SYSTEM ( PA LEVONORGESTREL RELEASING INTRAUTERINE CONTRACEPTIVE SYSTEM ( PA Lipodox PA Lucentis PA Lupaneta Pack PA Lupron Depot PA Lupron Depot Ped PA LYMPHOCYTE IMMUNE GLOBULIN, ANTITHYMOCYTE GLOBULIN, EQUINE, PA Macugen PA Makena PA Marqibo PA MEASLES, MUMPS AND RUBELLA VIRUS VACCINE (MMR), LIVE, FOR SU $0 PA MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (MMRV), LIVE, $0 PA Melphalan HCl PA MENINGOCOCCAL POLYSACCHARIDE VACCINE, SEROGROUPS A, C, Y, W $0 PA MENINGOCOCCAL RECOMBINANT LIPOPROTEIN VACCINE, SEROGROUP B ( $0 PA MENINGOCOCCAL RECOMBINANT PROTEIN AND OUTER MEMBRANE VESICLE $0 PA Mesna PA Mesnex PA Methotrexate PA METHOTREXATE SODIUM, 5 MG PA METHOTREXATE SODIUM, 50 MG 19 Mitomycin PA MITOMYCIN, OPHTHALMIC, 0.2 MG $0 PA Mitoxantrone HCl PA Moderiba PA Monovisc PA MUROMONAB CD3, PARENTERAL, 5 MG PA Mustargen PA Myalept PA Myleran PA Myobloc PA NASAL VACCINE INHALATION $0 PA

20 for pricing information Natpara PA Navelbine PA Neulasta PA Neupogen PA Nipent PA NOC DRUGS, INHALATION SOLUTION ADMINISTERED THROUGH DME PA NOC DRUGS, OTHER THAN INHALATION DRUGS, ADMINISTERED THROUGH PA Norditropin PA Nucala PA Nutropin PA Nutropin AQ PA Octagam PA Ofev PA Olysio PA Oncaspar PA Onivyde PA Opdivo PA Opsumit PA Oralair PA Orencia PA Orenitram PA Orkambi PA Orthovisc PA Otezla tablets PA Oxaliplatin PA Paclitaxel PA Pegasys PA PEG Intron PA PENTAMIDINE ISETHIONATE, INHALATION SOLUTION, FDA APPROVED F PA Perjeta PA PHARMACOLOGIC AGENT ADMINISTRATION (EG, INHALED NITRIC OXIDE PA Photofrin PA Plegridy PA PNEUMOCOCCAL CONJUGATE VACCINE, 13 VALENT (PCV13), FOR INTRA $0 PA PNEUMOCOCCAL POLYSACCHARIDE VACCINE, 23 VALENT (PPSV23), ADU $0 PA 20

21 for pricing information POLIOVIRUS VACCINE, INACTIVATED (IPV), FOR SUBCUTANEOUS OR I $0 PA Pomalyst PA Portrazza PA Praluent PA Privigen PA Procrit PA Prolastin C PA Proleukin PA Prolia PA Promacta PA Provenge PA Purixan PA RABIES IMMUNE GLOBULIN (RIG), HUMAN, FOR INTRAMUSCULAR AND/O PA RABIES IMMUNE GLOBULIN, HEAT TREATED (RIG HT), HUMAN, FOR IN PA RABIES VACCINE, FOR INTRAMUSCULAR USE $0 PA Rebetol PA Rebetol oral solution PA Rebif PA Reclast PA Remicade PA Remodulin PA Repatha PA RESPIRATORY SYNCYTIAL VIRUS, MONOCLONAL ANTIBODY, RECOMBINAN Revatio PA RHO(D) IMMUNE GLOBULIN (RHIG), HUMAN, FULL DOSE, FOR INTRAMU RHO(D) IMMUNE GLOBULIN (RHIG), HUMAN, MINI DOSE, FOR INTRAMU PA RHO(D) IMMUNE GLOBULIN (RHIGIV), HUMAN, FOR INTRAVENOUS USE Ribasphere PA RINGERS LACTATE INFUSION, UP TO 1000 CC PA Rituxan PA ROTAVIRUS VACCINE, HUMAN, ATTENUATED (RV1), 2 DOSE SCHEDULE, $0 PA ROTAVIRUS VACCINE, PENTAVALENT (RV5), 3 DOSE SCHEDULE, LIVE, $0 Ruconest PA Saizen PA 21

22 for pricing information Serostim PA Signifor PA Signifor LAR PA SILDENAFIL CITRATE, 25 MG PA Simponi Aria PA Simponi SC PA SIPULEUCEL T, MINIMUM OF 50 MILLION AUTOLOGOUS CD54+ CELLS A PA Sovaldi PA Stelara PA STERILE DILUTANT FOR EPOPROSTENOL, 50 ML PA SUBCUTANEOUS INFUSION FOR THERAPY OR PROPHYLAXIS (SPECIFY SU PA Supartz FX PA Sylatron PA Sylvant PA Synagis PA Synribo PA Synvisc, Synvisc One PA Taxotere PA Tecfidera PA Teniposide PA Testopel PA TETANUS AND DIPHTHERIA TOXOIDS ADSORBED (TD), PRESERVATIVE F $0 PA TETANUS IMMUNE GLOBULIN (TIG), HUMAN, FOR INTRAMUSCULAR USE PA TETANUS, DIPHTHERIA TOXOIDS AND ACELLULAR PERTUSSIS VACCINE $0 PA Theracys PA THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INJECTION (SPECIFY $0 PA THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INJECTION (SPECIFY PA THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INJECTION (SPECIFY PA THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INJECTION (SPECIFY PA THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INJECTION (SPECIFY PA Thiotepa PA Toposar PA Topotecan HCl PA Torisel PA Totect PA 22

23 for pricing information Tracleer PA Treanda PA Trelstar PA Trexall PA Trisenox PA TYPHOID VACCINE, LIVE, ORAL $0 PA TYPHOID VACCINE, VI CAPSULAR POLYSACCHARIDE (VICPS), FOR INT $0 PA Tysabri PA Tyvaso PA UNCLASSIFIED BIOLOGICS PA Unituxin PA UNLISTED THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INTRAVENOU PA UNLISTED VACCINE/TOXOID $0 PA Uptravi PA USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG $$$$$ PA VACCINIA IMMUNE GLOBULIN, HUMAN, FOR INTRAMUSCULAR USE PA Valchlor PA Valstar PA Vantas PA VARICELLA VIRUS VACCINE (VAR), LIVE, FOR SUBCUTANEOUS USE $0 PA VARICELLA ZOSTER IMMUNE GLOBULIN, HUMAN, FOR INTRAMUSCULAR U PA Vectibix PA Velcade PA Veletri PA Ventavis PA Vidaza PA Viekira Pak PA Vinblastine Sulfate PA Vincasar PFS PA Vincristine Sulfate PA VINCRISTINE SULFATE, 1 MG Vinorelbine Tartrate PA Xeljanz, Xeljanz XR PA Xeloda PA Xenazine PA Xeomin PA Xgeva PA 23

24 for pricing information Xofigo PA Xolair PA YELLOW FEVER VACCINE, LIVE, FOR SUBCUTANEOUS USE $0 PA Yervoy PA Yondelis PA Zaltrap PA Zanosar PA Zarxio PA Zemaira PA Zepatier PA Zevalin PA Zinecard PA Zoladex PA Zoledronic Acid PA Zolinza PA Zomacton PA Zometa PA Zorbtive PA HCR

The following are J Code requirements

The following are J Code requirements The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based

More information

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015 J0129 Injection, abatacept (Orencia ), 10 J0178 Injection, aflibercept (Eylea ), 1 J0256 J0257 J0585 J0586 J0587 J0588 J0597 J0641 J0717 J0800 Injection, alpha 1-proteinase inhibitor, human (Aralast NP,

More information

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Code Drug Name Effective and/or Term Date J0129 Injection, abatacept (Orencia ), 10 mg J0178 Injection, aflibercept (Eylea

More information

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19 Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19 All Non-Par Provider Requests Requires Authorization Regardless of Service J0178 J0180 J0202 J0205

More information

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364 G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288

More information

Injections Requiring Prior Authorization

Injections Requiring Prior Authorization At VIVA Health, we strive to keep our provider network informed of any changes. Most of you may currently obtain prior authorizations for administered injections. Below is a list of injection, infusion,

More information

Table III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent

Table III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent Table III: 2019 Medicare Drug Fee Schedule* CY 2019 1st Quarter Average Sales Price (ASP) Data Plus 6 Percent *The Medicare payments allowance limits are effective Jan. 1 thru March. 31, 2019. CY 2019

More information

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,

More information

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,

More information

MedStar Medicare Choice Pharmacy Services

MedStar Medicare Choice Pharmacy Services Pharmacy Services 1 MedStar Medicare Choice Pharmacy Services Table of Contents At a Glance..page 2 Pharmacy Policies..page 4 Medicare Choice Pharmacy Programs..page 6 Where to Obtain Prescriptions..page

More information

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015 Prior Authorization List 2015 Participating providers are responsible to furnish or arrange health care services with other participating healthcare facilities or providers. Prior authorization requests

More information

SPECIALTY PHARMACY Master Clinical Drug List

SPECIALTY PHARMACY Master Clinical Drug List Abraxane J9264 Provider ONCOLOGY None NO Actemra J3262 Provider ARTHRITIS PA - all YES Acthar HP Gel J0800 Prov/Self Med/Pharm ENDOCRINE/METABOLIC PA - all YES Adagen J2504 Provider ENZYME DISORDERS None

More information

Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017

Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017 Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017 NOTES: Claims payment is subject to member eligibility, benefit coverage and current

More information

IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR FEBRUARY 16, 2016

IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR FEBRUARY 16, 2016 IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR201607 FEBRUARY 16, 2016 HCPCS code J1458 linked to revenue code 636 Effective March 16, 2016, the Indiana Health Coverage Programs (IHCP) will link

More information

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019 5-Fluorouracil 5-FU, Fluorouracil Stability Indicating HPLC-UV USP 7-keto DHEA Stability Indicating HPLC-UV Medisca Tier 1 Acetaminophen Stability Indicating HPLC-UV USP Adenosine Alprostadil PGE-1, Prostaglandin

More information

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST PRIOR AUTHORIZATION LIST (SUBJECT TO CHANGE) MEDICATION THERAPEUTIC CATEGORY MODULE ACTEMRA INFLAMMATORY CONDITIONS ACTEMRA ADCIRCA PULMONARY HYPERTENSION PDE-5 INHIBITORS FOR PAH ADDYI SEXUAL DISORDERS

More information

A9542 A9543 A9545 A9699 J0120 J0128 J0129 J0130

A9542 A9543 A9545 A9699 J0120 J0128 J0129 J0130 Procedure Code 90378 A9542 A9543 Procedure Description Long RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN (RSV-IGIM), FOR INTRAMUSCULAR USE, 50 MG, EACH INDIUM IN-111 IBRITUMOMAB TIUXETAN, DIAGNOSTIC, PER

More information

List of Designated High-Cost Drugs

List of Designated High-Cost Drugs List of Designated High-Cost Drugs UPDATED APRIL 25, 2018 For details on the High-Cost Drug policy, see Section 5.8 of the PharmaCare Policy Manual. Recent updates appear in red. Deletions are listed at

More information

MDwise Self-Administered Codes for Medical

MDwise Self-Administered Codes for Medical The following codes are associated with medications that can be self-administered by the patient or a caregiver. As a result, MDwise will transfer coverage of these self-administered medications exclusively

More information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion

More information

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder. Prior Authorization PricewaterhouseCoopers The following medications may require prior authorization prior to dispensing at a participating retail pharmacy or through the Express Scripts Pharmacy home

More information

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3*

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3* ABA BEHAVIORAL HEALTH CHEMICAL DEPENDENCY Applied Behavioral Analysis stage 3* Neuropsychological Testing Chemical Dependency/Substance Abuse* (MA Only) 0364T 0365T 0366T 0367T 0373T 0374T H2020 96116

More information

Highmark List of Procedure Codes Requiring NDC Effective 12/01/2017

Highmark List of Procedure Codes Requiring NDC Effective 12/01/2017 90378 RESPIRATORY SYNCYTIAL VIRUS, MONOCLONAL ANTIBODY, RECOMBINANT, FOR INTRAMUSCULAR USE, 50 MG, EACH C9399 Unclassified Drugs or biologicals J0129 INJECTION, ABATACEPT, 10 MG J0130 INJECTION ABCIXIMAB,

More information

Drug Use Evaluation: Physician Administered Drugs (PADs)

Drug Use Evaluation: Physician Administered Drugs (PADs) Drug Use Research & Management Program OHA Division of Medical Assistance Programs 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Drug Use Evaluation: Physician Administered

More information

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed

More information

Benefit Interpretation

Benefit Interpretation Benefit Interpretation Subject: Part B vs. Part D Vaccines Issue Number: BI-039 Applies to: Medicare Advantage Effective Date: May 1, 2017 Attachments: Part B Vaccines Diagnosis Code Limits Table of Contents

More information

PA Category Name Code(s) Additional Notes ABA. Applied Behavioral Analysis stage 3*

PA Category Name Code(s) Additional Notes ABA. Applied Behavioral Analysis stage 3* ABA BEHAVIORAL HEALTH CHEMICAL DEPENDENCY Applied Behavioral Analysis stage 3* Neuropsychological Testing Chemical Dependency/Substance Abuse* (MA Only) 0373T H2020 96116 96112 96113 96121 96130 96131

More information

High Risk Medications

High Risk Medications Department Policy Code: D: MM-5705 Entity: Fairview Health Services Department: Home Infusion Manual: Policies & Procedures Category: Medication Management Subject: High Risk Medications Purpose: To provide

More information

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1 drug and administration compendia Current Price () J7506 Prednisone, oral, per 5 mg 12/1/07 $0.07 $0.19 N/A prednisone 2 J8520 capecitabine (Xeloda) 1 Capecitabine, oral, 150 mg 8/1/07 $5.79 $4.59 N/A

More information

CPT 2016 Code Changes

CPT 2016 Code Changes CPT 2016 Code Changes Code Changes - Medicine New CPT 2016 New Codes Code Description 69209 Removal impacted cerumen using irrigation/lavage, unilateral 90620 Meningococcal recombinant protein and outer

More information

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES CURRENT DRUG SHORTAGES (through February 22, 2013) CRITICAL SHORTAGES Acetylcysteine Inhalation Analgesic Buprenorphine Caffeine and Ergotamine Acyclovir Meperidine Injection Adenosine Amino Acid Products

More information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

New Billing Guidelines for Home Infusion, Enteral and Parenteral Therapies Home Infusion Fee Schedule Effective July 1, 2009

New Billing Guidelines for Home Infusion, Enteral and Parenteral Therapies Home Infusion Fee Schedule Effective July 1, 2009 STAT Bulletin PO Box 80 Buffalo, New York 14240-0080 May 12, 2009 Volume 15:Issue 18 To: All Home Health Care and Home Infusion Therapy Providers Contracts Effected: All Lines of Business New Billing Guidelines

More information

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions J9190 5-FU fluorouracil None. J0401 ABILIFY MAINTENA aripiprazole i.v. J9264 ABRAXANE paclitaxel protein bound J3262 ACTEMRA IV tocilizumab Yes, through Navitus. Restricted to (in at least consultation

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Routine Immunizations Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 3 References... 7 Effective Date... 4/15/2018

More information

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization 2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Requires PA Coding All Out of Network services

More information

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or Noridian Healthcare Solutions, LLC Jurisdiction F Part B Self-Administered Drug (SAD) Exclusion List (A53033); Effective 8/7/2017 The following medications are considered self-administered and are not

More information

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization 2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Requires PA Coding All Out of Network services

More information

Specialty Drug List - Sorted by Therapeutic Class Developed for the Mississippi Division of Medicaid by Mercer

Specialty Drug List - Sorted by Therapeutic Class Developed for the Mississippi Division of Medicaid by Mercer ANTI-INFECTIVE ABELCET 100 MG/20 ML VIAL 4/1/2017 ANTI-INFECTIVE AMBISOME 50 MG VIAL 4/1/2017 ANTI-INFECTIVE ANCOBON 250 MG CAPSULE 4/1/2017 ANTI-INFECTIVE ANCOBON 500 MG CAPSULE 4/1/2017 ANTI-INFECTIVE

More information

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC) INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193

More information

To help doctors give their patients the best possible care, the American

To help doctors give their patients the best possible care, the American Patient Information Resources from ASCO What to Know ASCO s Guideline on Preventing Vomiting Caused by Cancer Treatment SEPTEMBER 2011 KEY MESSAGES The risk of nausea and vomiting depends on the specific

More information

2017 MDwise HIP Medical Services that Require Prior Authorization

2017 MDwise HIP Medical Services that Require Prior Authorization 2017 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Requires PA Coding All Out of Network services Facility to facility ambulance

More information

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500

More information

2016 MDwise HIP Medical Services that Require Prior Authorization

2016 MDwise HIP Medical Services that Require Prior Authorization 2016 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Requires PA Coding All Out of Network services Facility to facility ambulance

More information

Committee Approval Date: December 12, 2014 Next Review Date: July 2015

Committee Approval Date: December 12, 2014 Next Review Date: July 2015 Medication Policy Manual Policy No: dru378 Topic: Akynzeo, netupitant/palonosetron Date of Origin: December 12, 2014 Committee Approval Date: December 12, 2014 Next Review Date: July 2015 Effective Date:

More information

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business STAT Bulletin November 28, 2011 Volume 9: Issue 27 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat

More information

Injectable Drugs Requiring Pre-Service Approval

Injectable Drugs Requiring Pre-Service Approval Abatacept Orencia J0129, 10 mg 1500 FL LCD- L29051 1) For patients with rheumatoid arthritis with failure, intolerance or contraindications to methotrexate. Limit dosing to 40 mg Q 2 weeks. 2) For patients

More information

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply. An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation

More information

Part B payment for drugs in Medicare 0

Part B payment for drugs in Medicare 0 Part B payment for drugs in Medicare 0 Introduction: The recent pilot proposal 1 on Part B drug payment from the Center for Medicare and Medicaid Innovation of CMS has met strong resistance 2 from the

More information

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply. An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation

More information

2018 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization 2018 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Requires PA Coding All Out of Network services Facility to facility ambulance

More information

SELF-ADMINISTERED MEDICATIONS LIST

SELF-ADMINISTERED MEDICATIONS LIST SELF-ADMINISTERED MEDICATIONS LIST Table of Contents Page Last Updated: January 23, 2019 INSTRUCTIONS FOR USE... 1 APPLICABLE CODES... 1 Related Commercial Policy LIST HISTORY/REVISION INFORMATION... 5

More information

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin Self-Administered Drug Exclusion List R2 This article from Medicare A News, Issue 2106 dated January 23, 2013 and Medicare B News, Issue 283 dated January 23, 2013 is being revised to add Acthar ACTH gel

More information

2018 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization 2018 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Requires PA Coding All Out of Network services Facility to facility ambulance

More information

Pharmacy and Medical Guideline Updates

Pharmacy and Medical Guideline Updates STAT Bulletin PO Box 15013 Albany, New York 12212 August 2, 2010 Volume 8: Issue 19 To: All PCPs and Specialists Contracts Affected: All Lines of Business Pharmacy and ical Guideline Updates As a result

More information

2018 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization 2018 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Requires PA Coding All Out of Network services Facility to facility ambulance

More information

Aetna Better Health. Specialty Drug Program

Aetna Better Health. Specialty Drug Program Aetna Better Health is managed through CVS Health Specialty Pharmacy. The Specialty pharmacies fill prescriptions and ship drugs for complex medical conditions, including multiple sclerosis, rheumatoid

More information

Child Health and Disability Prevention (CHDP) Program Code Conversion

Child Health and Disability Prevention (CHDP) Program Code Conversion Child Health and Disability Prevention (CHDP) Program Code Conversion Health s All s are effective for dates of service on or after July 1, 2017. (Select s for laboratory-only providers with effective

More information

Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care

Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care Raina H. Jain, Stephen M. Schleicher, Coral L. Atoria, Peter B. Bach Executive Summary The recent pilot

More information

Billing for Infusion Services in an Outpatient Neurology Clinic. Christine Mann, MBA Director of Infusion Services Dent Neurologic Institute

Billing for Infusion Services in an Outpatient Neurology Clinic. Christine Mann, MBA Director of Infusion Services Dent Neurologic Institute Billing for Infusion Services in an Outpatient Neurology Clinic Christine Mann, MBA Director of Infusion Services Dent Neurologic Institute Overview of Infusion Billing Codes Current Procedure Terminology

More information

DRUGS REQUIRING PRIOR AUTHORIZATION

DRUGS REQUIRING PRIOR AUTHORIZATION DRUGS REQUIRING PRIOR AUTHORIZATION Medication Abstral Actemra Acthar Gel Actiq* Adcirca Adderall Adderall XR Addyi Adempas Adipex* Adzenys XR-ODT Afinitor Afinitor Alecensa Alecensa Ampyra Androderm AndroGel

More information

Part B payment for drugs in Medicare 0

Part B payment for drugs in Medicare 0 Part B payment for drugs in Medicare 0 Introduction: The recent pilot proposal 1 on Part B drug payment from the Center for Medicare and Medicaid Innovation of CMS has met strong resistance 2 from the

More information

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies: VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Incidence: The incidence of acute and delayed N&V was investigated in highly and moderately emetogenic

More information

Re: Integrated Oncology Management Program with evicore healthcare: Update on codes requiring precertification

Re: Integrated Oncology Management Program with evicore healthcare: Update on codes requiring precertification Ajani Nimmagadda, MD Senior Medical Director , , Re: Integrated Oncology Management Program with evicore

More information

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business STAT Bulletin November 28, 2011 Volume 17: Issue 34 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat

More information

Appendix 1 Pregnancy Identification Algorithm

Appendix 1 Pregnancy Identification Algorithm Appendix 1 Pregnancy Identification Algorithm We used the following procedure to identify unique pregnancies in Oregon Medicaid, Emergency Medicaid and Emergency Medicaid Plus claims data from January

More information

2016 MDwise HIP Medical Services that Require Prior Authorization

2016 MDwise HIP Medical Services that Require Prior Authorization 2016 MDwise HIP Medical Services that Require Prior Authorization Medical services that require Prior Authorization Type of Service Coding All Out of Network services Facility to facility ambulance transport

More information

MDwise Hoosier Care Connect Medical Services that Require Prior Authorization

MDwise Hoosier Care Connect Medical Services that Require Prior Authorization MDwise Hoosier Care Connect Medical Services that Require Prior Authorization Certain Indiana Health Coverage Programs (IHCP) services require prior authorization (PA) for members enrolled in the Hoosier

More information

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY]

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY] Commercial Medical Oncology Program Review Code List 3rd Quarter 2018 This list is subject to change once per quarter. Changes will be posted to the BCBSNC website at www.bcbsnc.com by the 10th day of

More information

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site Supplementary Table 1. ICD-9-CM codes used to define cancer ICD-9 Diagnosis code 140.xx-172.xx 174.xx-195.xx 196.xx 198.xx 199.xx 200.xx-208.xx Description Primary malignant neoplasms, not lymphatic or

More information

CPT Service Description Effective Date

CPT Service Description Effective Date Medical Oncology Program Review Code List 2 nd Quarter 2018 This list is subject to change once per quarter. Changes will be posted to the BCBSNC website at www.bcbsnc.com by the 10th day of January, April,

More information

Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class

Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Cancer LAST REVIEW 9/11/18 THERAPEUTIC CLASS Oncology REVIEW HISTORY 5/17, 5/16 LOB AFFECTED Medi-Cal (MONTH/YEAR) This policy

More information

LIMITED DISTRIBUTION MEDICATIONS

LIMITED DISTRIBUTION MEDICATIONS ACTEMRA IV (USSC can dispense 162 mg PFS) ACTHAR HP ACTIMMUNE ADAGEN ADCETRIS CVS Specialty 1-800-237-2767 1-800-237-2767 ADEMPAS ADVATE ALDURAZYME ALECENSA ALIQOPA ALUNBRIG AMPYRA APOKYN ARALAST NP ARCALYST

More information

BULLETIN. PROFESSIONAL PROVIDERS Policy and Procedure Update PROFESSIONAL PROVIDER MANUAL REVISIONS

BULLETIN. PROFESSIONAL PROVIDERS Policy and Procedure Update PROFESSIONAL PROVIDER MANUAL REVISIONS JULY 2003 Kansas Medical Assistance Programs PROFESSIONAL PROVIDERS Policy and Update Reinstatement of Coverage of Audiology and Vision Services for Adults BULLETIN Effective with dates of service on and

More information

Essential Health Benefits Standard Specialty PA and QL List July 2016

Essential Health Benefits Standard Specialty PA and QL List July 2016 Anti-infectives Antiretrovirals, HIV SELZENTRY (maraviroc) Cardiology Antilipemic Pulmonary Arterial Hypertension Central Nervous System Anticonvulsants Depressant Neurotoxins Parkinson's Sleep Disorder

More information

Fee* Effective CPT Code Short Description

Fee* Effective CPT Code Short Description 90281 HUMAN IG, IM $70.38 90283 HUMAN IG, IV $42.84 90284 HUMAN IG, SC $10.71 90291 CMV IG, IV $1,311.21 90371 HEP B IG, IM $131.58 90375 RABIES IG, IM/SC $307.53 90376 RABIES IG, HEAT TREATED $338.13

More information

Fee* Effective CPT Code Short Description 02/15/2017

Fee* Effective CPT Code Short Description 02/15/2017 90281 HUMAN IG, IM $70.38 90283 HUMAN IG, IV $45.14 90284 HUMAN IG, SC $11.48 90291 CMV IG, IV $1,311.21 90371 HEP B IG, IM $131.58 90375 RABIES IG, IM/SC $307.53 90376 RABIES IG, HEAT TREATED $368.73

More information

07/20/17, 05/17/18 CATEGORY: Vaccines/Biologics. Proprietary Information of Excellus Health Plan, Inc.

07/20/17, 05/17/18 CATEGORY: Vaccines/Biologics. Proprietary Information of Excellus Health Plan, Inc. MEDICAL POLICY SUBJECT: IMMUNIZATIONS PAGE: 1 OF: 9 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including an Essential

More information

LDI integrated pharmacy services

LDI integrated pharmacy services 8 ARRANON CARIMUNE NF Immunodeficiency 8-MOP Psoriasis ARZERRA CAYSTON Cystic Fibrosis A ASTAGRAF XL Antirejection CERDELGA Gaucher's Disease abacavir ATRIPLA CEREZYME Gaucher's Disease abacavir/lamivudine/

More information

Coverage of Vaccines Medicaid and Child Health Plus Members

Coverage of Vaccines Medicaid and Child Health Plus Members Coverage of Vaccines Medicaid and Child Health Plus Members For children between the ages 0-18, routine recommended vaccinations are covered through Vaccines for Children program [VFC]. Fidelis Care will

More information

UP Health System Marquette Medication Guideline High Alert Drugs

UP Health System Marquette Medication Guideline High Alert Drugs 1 ALTEPLASE SOLR 100 MG ACTIVASE 305010 50242008527 TRUE ALTEPLASE SOLR 50 MG ACTIVASE 305008 50242004413 TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV 305035 63323061609 TRUE AMIODARONE INJ 50 MG/ML CORDARONE

More information

Medical Prior Authorization List Rosen Employee Plans For prescription drug requirements, contact EHIM toll-free at

Medical Prior Authorization List Rosen Employee Plans For prescription drug requirements, contact EHIM toll-free at For prescription drug requirements, contact EHIM toll-free at 1.800.311.3446. General Information These requirements are administered by Health First Health Plans ( Health Plan ). Benefits are determined

More information

Provider Bulletin April 2017

Provider Bulletin April 2017 Provider Bulletin April 2017 A bulletin for the Molina Healthcare of New York, Inc. Network (Formerly Total Care, A Today s Options of New York Health Plan) Questions? Call Provider Services (877) 872-4716

More information

Percent Brand Name Generic Name Strength How Supplied NDC from AWP/SWP Adcetris. Amprya dalfampridine 10 mg 60 count bottle

Percent Brand Name Generic Name Strength How Supplied NDC from AWP/SWP Adcetris. Amprya dalfampridine 10 mg 60 count bottle Department of General Services Procurement Division Contract # 01-14- 65-57 Pharmaceutical Acquisitions Section Exhibit G-1 April 30, 2015 Walgreens Specialty Pharmacy LLC, Products Pricing Crescent Healthcare,

More information

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole

More information

Ovarian Cancer. compendia TREATMENT OF

Ovarian Cancer. compendia TREATMENT OF drug & compendia TREATMENT OF Ovarian Cancer With each publication, ManagedCare Oncology s drug & Compendia highlights a single medication or a group of medications that could be utilized in the management

More information

Acute Lymphocytic Leukemia

Acute Lymphocytic Leukemia Acute Lymphocytic Leukemia Splenectomy (Removal of Spleen) 6-Mercaptopurine (Purinethol, 6-MP) Alemtuzumab (Campath ) Arsenic Trioxide (Trisenox ) Bendamustine (Treanda ) Bexarotene (Targretin ) Bleomycin

More information

Chemotherapy 101 for Radiation Oncology Workers

Chemotherapy 101 for Radiation Oncology Workers Chemotherapy 101 for Radiation Oncology Workers James Sinclair, M.D. CCARE/Medical Director Scripps Cancer Center March 9, 2013 Category 1) Alkylating agents Alkylating agents directly damage DNA to prevent

More information

after reconstitution No Yes Refrigerate; do Not freeze. Discard unused portions; do Not save for further Immune Deficiencies & Related

after reconstitution No Yes Refrigerate; do Not freeze. Discard unused portions; do Not save for further Immune Deficiencies & Related Store at room temp. Protect from bright light. Freezing or refrigerating do not adversely affect the stability of intact vials. Different standards apply Abraxane Oncology- Injectable IV No No Yes after

More information

BCN Advantage SM requirements for drugs covered under the medical benefit

BCN Advantage SM requirements for drugs covered under the medical benefit J0586 ABOBOTULINUMTOXINA Dysport X X X the medication is being used to treat J0178 AFLIBERCEPT Eylea X X X X X of Neovascular (Wet) -Related Macular Degeneration of Macular Edema following either central

More information

Drug Name Tier Drug Name Tier

Drug Name Tier Drug Name Tier Drug Name Tier Drug Name Tier ABELCET 100 MG/20 ML VIAL 4 ACETYLCYSTEINE 10% VIAL 2 ACETYLCYSTEINE 20% VIAL 2 ACYCLOVIR 1,000 MG/20 ML VIAL 2 ACYCLOVIR 500 MG/10 ML VIAL 2 ADRUCIL 500 MG/10 ML VIAL 2 ALBUTEROL

More information

Original Policy Date

Original Policy Date MP 5.01.17 Specialty Drugs Medical Policy Section Prescription Drug Issue 12:2013 Original Policy Date 12:2013 Last Review Status/ Date Local policy Last updated/12:2013 Return to Medical Policy Index

More information

Pharmacy Services Request Types

Pharmacy Services Request Types FOR DRUG REQUESTS, ONLY-- * NOTE: Only those drugs administered by a healthcare provider and billed medically would be entered via CareAffiliate. * Oral drugs would not be administered by a healthcare

More information

Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.

Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04. ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.

More information

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document

More information